Weight loss drugs Ozempic, Wegovy may be right for investors
Breakthroughs in the effectiveness of a class of medicines designed to treat diabetes have become the most talked about drug developments…
Breakthroughs in the effectiveness of a class of medicines designed to treat diabetes have become the most talked about drug developments…
Targeting travel and tourism through a travel ETF can pay off handsomely if activity continues to pick up and exceed 2019 levels…
Harvest ETFs Chief Investment Officer & Portfolio Manager Paul MacDonald explains how treatments like Ozempic are changing…
Harvest Portfolios Group…
Harvest Portfolios Group Inc. (“Harvest”) announces the following distributions for Harvest ETFs…
Senior Portfolio Manager James Learmonth joins the podcast to break down tech’s performance drivers this year and in the long term
Harvest Portfolios Group…
Harvest Portfolios Group…
Harvest Portfolios Group Inc. (“Harvest”) announces the following distributions for Harvest ETFs…
Harvest Portfolios Group…
Harvest ETFs President & CEO Michael Kovacs explains how the Harvest Tech Achievers Growth & Income ETF delivers access to…
Harvest Portfolios Group…